Physicians Group Services PA
Physicians Group Services PA was paid $3.96M by Medicaid between Jan 2018 and Dec 2024, across 113 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 32% of everything it billed.
ORANGE PARK, FL 32073
Next to other Internal Medicine Physician providers in Florida
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,062 | $37K | |
| 2019 | 118,684 | $1.94M | |
| 2020 | 98,941 | $1.36M | |
| 2021 | 61,880 | $505K | |
| 2022 | 27,136 | $102K | |
| 2023 | 10,067 | $7K | |
| 2024incomplete | 5,166 | $12K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 32% | 14,493 | 12,373 | $1.29M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 55,458 | 47,054 | $1.23M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 34,110 | 30,124 | $870K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.8% | 1,960 | 1,941 | $153K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.1% | 1,599 | 1,555 | $124K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.4% | 1,276 | 1,217 | $97K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 511 | 502 | $39K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 330 | 306 | $33K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 4,617 | 4,529 | $15K |
| 64493 | <1% | 89 | 81 | $15K | |
| 90698 | <1% | 693 | 689 | $14K | |
| 80356 | <1% | 6,321 | 5,555 | $7K |
101 more codes
| 99203 | Doctor's office visit, new patient (routine) | <1% | 106 | $6K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 190 | $6K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,105 | $5K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 193 | $5K |
| 80348 | <1% | 6,947 | $4K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 701 | $4K |
| 80354 | <1% | 6,962 | $4K | |
| 80361 | <1% | 5,382 | $4K | |
| 80358 | <1% | 6,593 | $4K | |
| 80362 | <1% | 5,391 | $3K | |
| 80365 | <1% | 4,818 | $3K | |
| 99381 | <1% | 39 | $3K | |
| 90633 | <1% | 349 | $3K | |
| 90961 | <1% | 235 | $2K | |
| 90744 | <1% | 256 | $2K | |
| 90686 | <1% | 627 | $2K | |
| 80346 | <1% | 1,940 | $2K | |
| 80324 | <1% | 1,386 | $2K | |
| 01936 | <1% | 38 | $2K | |
| 99442 | <1% | 118 | $2K | |
| 80353 | <1% | 1,894 | $1K | |
| 90707 | <1% | 37 | $1K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 107 | $903.44 |
| 90700 | <1% | 26 | $890.18 | |
| 80372 | <1% | 504 | $592.30 | |
| 90651 | <1% | 70 | $580.00 | |
| 90461 | <1% | 1,810 | $576.00 | |
| 01992 | <1% | 12 | $533.31 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 397 | $508.99 |
| 36415 | Collection of venous blood by venipuncture | <1% | 622 | $492.01 |
| 20553 | <1% | 432 | $473.19 | |
| 90696 | <1% | 24 | $430.00 | |
| 80359 | <1% | 415 | $325.50 | |
| 20610 | <1% | 24 | $321.11 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 2,159 | $316.21 |
| 80373 | <1% | 37 | $238.00 | |
| 90670 | <1% | 1,200 | $230.00 | |
| 99173 | <1% | 321 | $218.83 | |
| 11721 | <1% | 113 | $208.37 | |
| 80053 | Comprehensive metabolic panel | <1% | 13 | $191.60 |
| 72100 | <1% | 71 | $171.12 | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 92 | $142.66 |
| 81002 | <1% | 1,000 | $114.53 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 216 | $95.91 |
| 97597 | <1% | 16 | $88.30 | |
| 93000 | <1% | 28 | $87.93 | |
| 81025 | <1% | 1,189 | $82.43 | |
| 90680 | <1% | 559 | $70.00 | |
| 1031F | <1% | 5,299 | $65.15 | |
| 20550 | <1% | 69 | $62.31 | |
| 90734 | <1% | 30 | $60.00 | |
| 90648 | <1% | 49 | $60.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 238 | $59.23 |
| 64495 | <1% | 59 | $57.01 | |
| 64494 | <1% | 89 | $57.01 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 211 | $50.89 |
| 1125F | <1% | 6,213 | $48.73 | |
| 1159F | <1% | 13,530 | $33.73 | |
| 3074F | <1% | 11,402 | $33.05 | |
| 73630 | <1% | 21 | $32.22 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 193 | $26.10 |
| 90756 | <1% | 13 | $21.22 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 135 | $19.86 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 10,868 | $17.33 |
| 80061 | Lipid panel | <1% | 14 | $16.60 |
| 99407 | <1% | 305 | $14.60 | |
| 2000F | <1% | 18,296 | $13.29 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 146 | $11.86 |
| 1160F | <1% | 14,333 | $10.63 | |
| 90715 | <1% | 12 | $10.00 | |
| 90710 | <1% | 29 | $10.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 81 | $1.93 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 148 | $0.85 |
| 1126F | <1% | 6,249 | $0.71 | |
| 3078F | <1% | 10,819 | $0.55 | |
| 99499 | <1% | 110 | $0.48 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | <1% | 2,940 | $0.16 |
| 3061F | <1% | 34 | $0.14 | |
| 3079F | <1% | 3,616 | $0.13 | |
| 2001F | <1% | 19,636 | $0.13 | |
| 3075F | <1% | 920 | $0.10 | |
| 3008F | <1% | 21,241 | $0.05 | |
| 3077F | <1% | 404 | $0.03 | |
| 1034F | <1% | 780 | $0.03 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 32 | $0.01 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 2,100 | $0.00 |
| 0521F | 0% | 97 | $0.00 | |
| 1032F | 0% | 48 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 123 | $0.00 |
| 3080F | 0% | 494 | $0.00 | |
| 1000F | 0% | 76 | $0.00 | |
| 1036F | 0% | 1,049 | $0.00 | |
| 90716 | 0% | 24 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 15 | $0.00 |
| 1111F | 0% | 34 | $0.00 | |
| 96127 | 0% | 16 | $0.00 | |
| 4188F | 0% | 12 | $0.00 | |
| 1170F | 0% | 14 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 22 | $0.00 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 14 | $0.00 |
| 99406 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Physicians Group Services PA | Orange Park, FL | $703K |
| Physicians Group Services PA | Jacksonville, FL | $88K |
| Physicians Group Services PA | Jacksonville, FL | $71K |
| Physicians Group Services PA | Orange Park, FL | $54K |
| Camden Healthcare Associates, INC. | Kingsland, GA | $44K |
| Physicians Group Services PA | Middleburg, FL | $26K |
| Physicians Group Services PA | Orange Park, FL | $15K |
| Physicians Group Services PA | Orange Park, FL | $14K |
| Physicians Group Services PA | Jacksonville, FL | $12K |
| Physicians Group Services PA | Yulee, FL | $11K |
| Physicians Group Services PA | Middleburg, FL | $6K |
| Physicians Group Services PA | Jacksonville, FL | $6K |
| Physicians Group Services PA | Middleburg, FL | $6K |
| Physicians Group Services PA | Jacksonville, FL | $4K |
| Physicians Group Services PA | Jacksonville, FL | $4K |
| Physicians Group Services PA | Fleming Island, FL | $3K |
| Physicians Group Services PA | Lake City, FL | $721.76 |
| Physicians Group Services PA | Jacksonville Beach, FL | $98.06 |
| Physicians Group Services PA | Yulee, FL | $19.71 |
| Physicians Group Services PA | Jacksonville, FL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.